Bain Capital Life Sciences

Venture capital

Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
14Deep-tech portfolio7 active
7Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Imperative Care
13Co-investorsShare a portfolio company
Matched to tracked deep-tech companies

Portfolio · 14 companies

CompanySectorStatusLatest raiseRaised
Imperative CareMedtechActiveMar 20, 2026$575.8M
Cardurion PharmaceuticalsBiotechActiveJul 24, 2024$349.7M
CereVascMedtechActiveJun 5, 2020$11.1M
Beeline MedicinesBiotechActive——
Emalex BiosciencesBiotechActive——
HotSpot TherapeuticsBiotechActive——
Syremis TherapeuticsBiotechActive——
X4 PharmaceuticalsBiotechPublicAug 25, 2025$313.3M
Neurona TherapeuticsBiotechAcquiredApr 4, 2025$282.8M
Jnana TherapeuticsBiotechAcquiredJan 26, 2024$110.0M
Rapid Micro BiosystemsMedtechPublicAug 14, 2019$119.8M
Cabaletta BioBiotechPublicJan 14, 2019$88.3M
C4 TherapeuticsBiotechPublicJan 11, 2016$70.3M
Upstream BioBiotechPublic——
Among 276 venture investors with portfolios

Peer ranks

Portfolio size#33
Portfolio exits#26
Raises, 12 months#22
Co-investors#144
Share the most portfolio companies

Co-investors

Portfolio by sector

Sectors

  • Biotech11
  • Medtech3

Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.